1024655-19-3

Basic information

• Product Name: 1-pentyl-4-(4-methylphenyl)-1H-[1,2,3]triazole
• Synonyms: 1-pentyl-4-(4-methylphenyl)-1H-[1,2,3]triazole
• CAS NO: 1024655-19-3
• Molecular Weight: 229.325
• Mol File: 1024655-19-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-pentyl-4-(4-methylphenyl)-1H-[1,2,3]triazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-pentyl-4-(4-methylphenyl)-1H-[1,2,3]triazole(1024655-19-3)
• EPA Substance Registry System: 1-pentyl-4-(4-methylphenyl)-1H-[1,2,3]triazole(1024655-19-3)

Safety Data

• Hazardous Substances Data: 1024655-19-3(Hazardous Substances Data)

Upstream product

• 26330-06-3 pentyl azide 
• 766-97-2 4-n-methylphenylacetylene 
• 110-53-2 1-Bromopentane 
• 5301-96-2 4-(p-tolyl)-1H-[1,2,3]triazole 

Relevant articles and documents

Synthesis, characterization and catalytic properties of a copper-containing polyoxovanadate nanocluster in azide–alkyne cycloaddition

A copper-containing polyoxovanadate nanocluster, [(C2H5)4N]4[V8Cu2O24]?2H2O (1), was synthesized through reaction between the Cu(NO3)2?3H2O and [(C2H5)4N]4VO3 in the molar ratio 1 : 4. Nanocluster 1 was characterized by IR, elemental analysis, XRD, SEM, TEM, and X-ray crystallography. The catalytic activity of 1 for the azide–alkyne cycloaddition of different terminal alkynes and organic azides generated in situ from sodium azide and different organic halides was tested. The protocol could afford the corresponding products in good to excellent yield at very low catalyst loadings (3.4 Mol%) under the optimized reaction conditions.

ZnO nanoparticles: Efficient and versatile reagents for synthesis of 1,4-disubstituted 1,2,3-triazoles

Reaction between azides and acetylenes catalysed by ZnO nanoparticles (ZnO NPs) in solvent EtOH at room temperature provide a simple and efficient one-pot route for the synthesis of 1,4-disubstituted 1,2,3-triazoles in excellent yields. 1,2,3-Triazoles ar

1,2,3-Triazole derivatives as cannabinoid-receptor modulators

The invention relates to the use of compounds having pharmacological activity towards the so-called cannabonid receptors, and more particularly to some 1,2,3-triazole derivatives of formula (I): to processes of preparation of such compounds and to pharmac